Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 10/20 | 0.54 |
| ▸ | KYNU | Q16719 | 1/20 | 0.51 |
| ▸ | CTSK | P43235 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3948746 | 1.00 | P2RX7 (0.54) | P2RX7KYNUCTSKALDH1A1ALOX15 | |
| SCHEMBL3957822 | 0.92 | P2RX7 (0.54) | P2RX7CTSKCTSLLMNA | |
| SCHEMBL28450226 | 0.91 | P2RX7 (0.50) | P2RX7CTSKCTSLCA5ALMNA | |
| SCHEMBL8932365 | 0.90 | CA1 (0.47) | P2RX7CTSKALDH1A1LMNA | |
| SCHEMBL3652008 | 0.86 | P2RX7 (0.51) | P2RX7CTSKCA5ALMNA | |
| SCHEMBL3652010 | 0.86 | P2RX7 (0.51) | P2RX7CTSKCA5ALMNA | |
| SCHEMBL22552853 | 0.86 | P2RX7 (0.51) | P2RX7CTSKCA5ALMNA | |
| SCHEMBL38652164 | 0.85 | P2RX7 (0.55) | P2RX7ALDH1A1LMNA | |
| SCHEMBL17471772 | 0.85 | P2RX7 (0.55) | P2RX7ALDH1A1LMNA | |
| SCHEMBL7100122 | 0.84 | P2RX7 (0.49) | P2RX7ALDH1A1CTSLLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024237543-A1 | MULTI-FUNCTIONAL PARTICLES FOR NEAR-INFRARED IMAGING GUIDANCE AND PHOTOTHERMAL THERAPY AND COMPOSITE COMPRISING SAME | 한양대학교 산학협력단 | 2024-11-21 | — | — | WO | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| US-20230173098-A1 | NANOPARTICLE COMPLEX FOR ORAL ADMINISTRATION AND USES THEREOF | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) | 2023-06-08 | — | — | US | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| US-11369425-B2 | Lactoferrin-conjugated nanoparticle complex and use thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) | 2022-06-28 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| EP-1236715-B1 | Process for S-Aryl cysteine | HOFFMANN LA ROCHE (CH) | 2008-10-15 | — | — | EP | disclosed |
| EP-1812383-A1 | GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | Smithkline Beecham Corporation (US) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006052722-A1 | GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | SMITHKLINE BEECHAM CORPORATION (US) | 2006-05-18 | — | — | WO | disclosed |
| EP-0897911-B9 | PROCESS FOR PRODUCING CYSTEINE DERIVATIVES | KANEKA CORP (JP) | 2004-12-01 | — | — | EP | disclosed |
| US-6765109-B1 | FORMATION OF ENANTIOSELECTIVE MATERIAL; REACTING ARYL THIOL AND PROTECTED SERINE DERIVATIVE | ROCHE COLORADO CORPORATION | 2004-07-20 | — | — | US | disclosed |
| EP-0897911-B1 | PROCESS FOR PRODUCING CYSTEINE DERIVATIVES | KANEKA CORP (JP) | 2004-06-09 | — | — | EP | disclosed |
| EP-1236715-A2 | Process for S-Aryl cysteine | F. HOFFMANN-LA ROCHE AG (CH) | 2002-09-04 | — | — | EP | disclosed |
| US-6229041-B1 | COUPLING CYSTEINE WITH COPPER OR COPPER OXIDE TO GENERATE METAL-AMINO COMPLEX, THEN CONTACTING WITH ARYL-HALIDE TO PRODUCE 3-ARYL-CYSTEINE; XENOBIOTIC METABOLIC PATHWAYS; TARGETTING HIV VIRUS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-05-08 | — | — | US | disclosed |
| EP-0968997-A2 | Process for S-aryl-L-cysteine and derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2000-01-05 | — | — | EP | disclosed |
| US-6011170-A | SULFIDING A PROTECTED CYSTEINE DERIVATIVE WITH A MERCAPTAN WHEREIN THE REACTION IS CONDUCTED IN THE PRESENCE OF A BASE AND WATER IN AN ORGANIC REACTION SOLVENT. | KANEKA CORPORATION (JP) | 2000-01-04 | — | — | US | disclosed |
| EP-0897911-A1 | PROCESS FOR PRODUCING CYSTEINE DERIVATIVES | KANEKA CORPORATION (JP) | 1999-02-24 | — | — | EP | disclosed |